Cidofovir: Structure and Activation
Chemically, Cidofovirum is a nucleotide analogue of cytidine that already contains one phosphate group. Its key feature is that the process of metabolism and conversion into its active form (cidofovir diphosphate) is completely independent of viral enzymes. Activation is carried out exclusively by cellular kinases in both infected and healthy cells of the body. Due to this property, the drug successfully overcomes resistance associated with UL97 kinase mutations.
Molecular Mechanism of Action of Cidofovir
The amplitude of the therapeutic effect of cidofovir diphosphate is realized through two main stages:
- Competitive inhibition: the active form of the drug competes with natural deoxycytidine for binding to viral DNA polymerase.
- Chain termination: by incorporating into the growing viral DNA chain, the compound delays and completely halts its further elongation.
The drug demonstrates high selectivity: it suppresses viral DNA polymerases (including cytomegalovirus and herpes simplex virus) at concentrations hundreds of times lower than those required to inhibit human DNA polymerase.
Foscarnet: General Characteristics and Spectrum
Foscarnet sodium (Foscarnetum) belongs to non-nucleoside DNA polymerase inhibitors and is an inorganic compound, a pyrophosphate derivative. The drug has a wide spectrum of activity affecting all herpesviruses (including ganciclovir-resistant CMV strains), as well as the human immunodeficiency virus (HIV).
Mechanism of Action and Pharmacokinetics of Foscarnet
The target of Foscarnet is viral DNA polymerase in herpesviruses and reverse transcriptase in HIV. The molecular mechanism involves binding to the pyrophosphate-binding site of the enzyme, which blocks the cleavage of pyrophosphate from deoxynucleoside triphosphate. This disrupts nucleotide incorporation into the DNA chain and halts viral nucleic acid synthesis. Its inhibitory effect on viral polymerase is more than 100 times greater than its effect on the human enzyme.
Pharmacokinetically, Foscarnet is characterized by low bioavailability upon oral administration, so its primary route of administration is intravenous. The main indications for prescription are cytomegalovirus retinitis (primarily in AIDS patients) and other severe CMV infections.
Briefly: answers to topical questions
Which viruses are included in the spectrum of antiviral activity of cidofovir?
The spectrum of antiviral activity of cidofovir includes the following pathogens:
- Cytomegalovirus — viral replication is suppressed.
- Herpes simplex virus — viral DNA polymerase is inhibited.
To achieve an antiviral effect, drug concentrations are required that are hundreds of times lower than those needed to inhibit the analogous enzyme in healthy human cells.
What specific side effects does foscarnet cause?
A specific side effect of foscarnet is pronounced nephrotoxicity. Due to the high risk of toxic kidney damage, this medication is used primarily as a second-line drug.
Indications for switching to foscarnet:
- Resistance — inefficacy of prior therapy.
- Contraindications to ganciclovir — presence of moderate or severe thrombocytopenia in the patient.
Class and exam questions
What is the main difference in the chemical structure of cidofovir from classic nucleosides?
Cidofovir is a nucleotide analogue and already contains a single phosphate group in its structure, which frees it from the need for initial phosphorylation by viral enzymes.
Which enzymes activate cidofovir in the body?
Activation of the drug to diphosphate occurs exclusively under the action of cellular kinases in both healthy and infected cells.
To which chemical class does foscarnet belong and what is its route of administration?
Foscarnet is an inorganic compound, a pyrophosphate derivative. Due to its low oral bioavailability, it is administered exclusively intravenously.
What is resistance to cidofovir associated with?
Resistance to the drug is due to mutations in the viral DNA polymerase gene itself, rather than changes in kinases.
What else to study on this topic
- Mechanisms of resistance development to cidofovir at the DNA polymerase level
- Comparative analysis of the selectivity of viral and cellular polymerase inhibition
- Features of phosphorylation of nucleoside and nucleotide analogues
- Spectrum of antiviral activity of foscarnet against resistant herpesvirus strains
- Pharmacokinetic features of intravenous foscarnet use in HIV infection
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Cidofovir and Foscarnet" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Antivirals" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.